Celltrion
068270.KS
#754
Rank
NZ$45.04 B
Marketcap
$217.49
Share price
0.72%
Change (1 day)
6.46%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): $4.92

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $5.01. In 2022 the company made an earnings per share (EPS) of $4.87 a decrease over its 2021 EPS that were of $5.79.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.920.94%
2022$4.87-15.84%
2021$5.7912.77%
2020$5.1470.79%
2019$3.0115.63%
2018$2.60-33.13%
2017$3.89141.17%
2016$1.618.28%
2015$1.4911.28%
2014$1.3416.37%
2013$1.15-67.42%
2012$3.5384.22%
2011$1.9262.13%
2010$1.1880.61%
2009$0.65-559.63%
2008-$0.14-123.16%
2007$0.61